WILMINGTON, Del. / Dec 12, 2023 / Business Wire / Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of January:
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
| Last Trade: | US$68.84 |
| Daily Change: | 1.78 2.65 |
| Daily Volume: | 5,651,580 |
| Market Cap: | US$13.260B |
December 17, 2024 November 25, 2024 November 18, 2024 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
